Cascadian Therapeutics Inc (CASC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2007 | 12-2006 | 12-2005 | 12-2004 | 12-2003 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -20,428 | -36,394 | -10,840 | -10,150 | -14,670 |
| Depreciation Amortization | 246 | 247 | 224 | 340 | 340 |
| Accounts receivable | 10 | -17 | -448 | 0 | 0 |
| Accounts payable and accrued liabilities | -181 | 12 | 718 | 0 | 0 |
| Other Working Capital | -2,866 | -1,194 | -157 | -1,370 | -3,370 |
| Other Operating Activity | 16,188 | 23,662 | -4,113 | -4,070 | -710 |
| Operating Cash Flow | $-7,031 | $-13,684 | $-14,616 | $-15,250 | $-18,410 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 5,081 | -4,492 | 5,448 | 0 | 0 |
| PPE Investments | -684 | -71 | -325 | -100 | 50 |
| Net Acquisitions | -238 | -3,874 | N/A | 0 | 0 |
| Other Investing Activity | 0 | -356 | 0 | -1,510 | 8,690 |
| Investing Cash Flow | $4,159 | $-8,793 | $5,123 | $-1,610 | $8,740 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -71 | -54 | -12 | 0 | 0 |
| Common Stock Issued | -165 | 27,735 | 712 | 0 | 0 |
| Other Financing Activity | 0 | 0 | 0 | 13,600 | 21,850 |
| Financing Cash Flow | $-236 | $27,681 | $700 | $13,600 | $21,850 |
| Exchange Rate Effect | 1,734 | 259 | 216 | -200 | -140 |
| Beginning Cash Position | 13,409 | 7,946 | 16,523 | 19,990 | 6,580 |
| End Cash Position | 12,035 | 13,409 | 7,946 | 16,520 | 18,610 |
| Net Cash Flow | $-1,374 | $5,463 | $-8,577 | $-3,460 | $12,030 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,031 | -13,684 | -14,616 | -15,250 | -18,410 |
| Capital Expenditure | -684 | -71 | -325 | 0 | 0 |
| Free Cash Flow | -7,715 | -13,755 | -14,941 | -15,250 | -18,410 |